Comparative Outcomes of Relapsed Follicular Lymphoma Patients Treated with Novel Agents: A Multi-Center Analysis

Background: Follicular lymphoma (FL) is the most common indolent lymphoma and is generally characterized by prolonged survival with multiple relapses throughout the disease course. There is no standard of care as to the initial choice or sequencing of treatments for relapsed disease. Novel agents ap...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2019-11, Vol.134 (Supplement_1), p.3982-3982
Hauptverfasser: Winter, Allison M., Wei, Wei, Ayers, Emily C., Landsburg, Daniel J., Raya, Saba, Kahl, Brad S., Rogers, Andrew, Maddocks, Kami J., Khan, Mohammad, Kittai, Adam S., Danilov, Alexey, Ujjani, Chaitra S., Lynch, Ryan C., Nastoupil, Loretta J., Becnel, Melody R., Zurbriggen, Luke, Kenkre, Vaishalee P., Sheela, Sheenu, Ghosh, Nilanjan, Hu, Boyu, Stephens, Deborah M., Ayers, Amy, Cohen, Jonathon B., Hill, Brian T.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!